BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 34528699)

  • 1. M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.
    Xie J; Zhang H; Wang K; Ni J; Ma X; Khoury CJ; Prifti V; Hoard B; Cerenzia EG; Yin L; Zhang H; Wang R; Zhuo D; Mao W; Peng B
    Oncogene; 2023 Sep; 42(40):2956-2970. PubMed ID: 37612524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated Proteins from Serum: A Promising Potential Diagnostic Biomarker of Cancer.
    Ghosh R; Ahmed R; Ahmed H; Chatterjee BP
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma.
    Wei Z; Cheng G; Ye Y; Le C; Miao Q; Chen J; Yang H; Zhang X
    Front Genet; 2022; 13():894736. PubMed ID: 35873479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems.
    Rodrigues D; Monteiro M; Jerónimo C; Henrique R; Belo L; Bastos ML; Guedes de Pinho P; Carvalho M
    Transl Res; 2017 Feb; 180():1-11. PubMed ID: 27546593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of Metabolism in Kidney Cancer.
    Wettersten HI
    Semin Nephrol; 2020 Jan; 40(1):2-13. PubMed ID: 32130963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative global proteome and phosphorylome analyses reveal potential biomarkers in kidney cancer.
    Xu L; Lu Z; Yu S; Li G; Chen Y
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34528699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Global Proteome and Lysine Succinylome Analyses Reveal the Effects of Energy Metabolism in Renal Cell Carcinoma.
    Zhang N; Gao R; Yang J; Zhu Y; Zhang Z; Xu X; Wang J; Liu X; Li Z; Li Z; Gong D; Li J; Bi J; Kong C
    Proteomics; 2018 Oct; 18(19):e1800001. PubMed ID: 29882248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
    Raimondo F; Corbetta S; Savoia A; Chinello C; Cazzaniga M; Rocco F; Bosari S; Grasso M; Bovo G; Magni F; Pitto M
    Mol Biosyst; 2015 Jun; 11(6):1708-16. PubMed ID: 25926002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.
    Sun X; Zhang H; Luo L; Zhong K; Ma Y; Fan L; Fu D; Wan L
    Oncol Rep; 2016 Dec; 36(6):3131-3138. PubMed ID: 27748938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
    Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
    Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
    BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment of renal cell cancer: A comprehensive review.
    Sánchez-Gastaldo A; Kempf E; González Del Alba A; Duran I
    Cancer Treat Rev; 2017 Nov; 60():77-89. PubMed ID: 28898679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors.
    Andrejeva G; Rathmell JC
    Cell Metab; 2017 Jul; 26(1):49-70. PubMed ID: 28683294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy.
    Zarrabi K; Fang C; Wu S
    J Hematol Oncol; 2017 Feb; 10(1):38. PubMed ID: 28153029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation Is a Central Mechanism for Circadian Control of Metabolism and Physiology.
    Robles MS; Humphrey SJ; Mann M
    Cell Metab; 2017 Jan; 25(1):118-127. PubMed ID: 27818261
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.